ArticlebioRxiv : the preprint server for biology2024
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy.
Bocheng Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.